The Greater Cannabis Company, Inc. (GCAN)

OTCMKTS · Delayed Price · Currency is USD
0.174
-0.044 (-20.05%)
At close: Mar 6, 2026
-80.72%
Market Cap 163.95K
Revenue (ttm) n/a
Net Income (ttm) -712.72K
Shares Out 944.94K
EPS (ttm) -0.98
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 131
Average Volume 11,059
Open 0.174
Previous Close 0.217
Day's Range 0.174 - 0.174
52-Week Range 0.036 - 3.600
Beta 0.55
RSI 48.62
Earnings Date Apr 2, 2026

About GCAN

The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland. [Read more]

Sector Healthcare
Founded 2014
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol GCAN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.